Recruitment for a trial investigating the preventive effect on asthma of an SQ-standardised grass allergy immunotherapy tablet in children with grass pollen-induced rhinoconjunctivitis

被引：0

作者：

Roberts, G. ^{[1
]}

Berstad, A. ^{[2
]}

de Blic, J. ^{[3
]}

Bufe, A. ^{[4
]}

Eng, P. ^{[5
]}

Halken, S. ^{[6
]}

Ojeda, P. ^{[7
]}

Tommerup, L. ^{[8
]}

Valovirta, E. ^{[9
]}

Varga, E. ^{[10
]}

Winnergard, I ^{[11
]}

机构：

[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England

[2] Haukeland Hosp, N-5021 Bergen, Norway

[3] Hop Necker Enfants Malad, Paris, France

[4] NETSTAP Forsch, Bochum, Germany

[5] Trimbach, Gosgen, Switzerland

[6] Odense Univ Hosp, DK-5000 Odense, Denmark

[7] Clin Asma & Alergia, Madrid, Spain

[8] ALK, Horsholm, Denmark

[9] Suomen Terveystalo Allergy Clin, Turku, Finland

[10] Med Univ Graz, Dept Paediat, Resp & Allerg Dis Div, Graz, Austria

[11] Pediat Allergy Clin, Kungsbacka, Sweden

来源：

ALLERGY | 2011年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

507

引用

页码：209 / 210

页数：2

共 50 条

[1] Asthma prevention trial of an SQ-standardised grass allergy immunotherapy tablet for children with grass pollen-induced rhinoconjunctivitis: preliminary baseline characteristics
Roberts, G.
Berstad, A.
de Blic, J.
Bufe, A.
Ebbesen, D.
Eng, P.
Halken, S.
Laursen, M.
Ojeda, P.
Varga, E.
Winnergard, I
ALLERGY, 2012, 67 : 417 - 417
[2] Investigating the asthma preventive effect of the SQ-standardised grass allergy immunotherapy tablet in grass allergic children - the GAP trial
Valovirta, E.
Ljorring, C.
Tommerup, L.
ALLERGY, 2010, 65 : 309 - 309
[3] Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen-Induced Allergic Rhinoconjunctivitis
Valovirta, Erkka
Berstad, Aud Katrine Herland
de Blic, Jacques
Bufe, Albrecht
Eng, Peter
Halken, Susanne
Ojeda, Pedro
Roberts, Graham
Tommerup, Lene
Varga, Eva-Maria
Winnergard, Inger
CLINICAL THERAPEUTICS, 2011, 33 (10) : 1537 - 1546
[4] Effect of the SQ-standardised grass allergy immunotherapy tablet on immunological compartment in patients with grass pollen induced rhinoconjunctivitis
Rumi, C.
Rumi, G.
Romano, A.
Milani, M.
ALLERGY, 2010, 65 : 268 - 268
[5] A comparative health economic evaluation of the SQ-standardised grass allergy immunotherapy tablet and subcutaneous immunotherapy in the treatment of grass pollen induced allergic rhinoconjunctivitis
Ronborg, S.
Svendsen, U.
Micheelsen, J.
Ytte, L.
Treloggen, Riss J.
Andreasen, J.
Ehlers, L.
ALLERGY, 2011, 66 : 629 - 629
[6] SQ-standardised grass allergy immunotherapy tablet treatment did not result in asthma worsening in subjects with allergic grass pollen rhinoconjunctivitis with or without seasonal asthma
Dahl, R.
Nolte, H.
Nelson, H.
Blaiss, M.
Bufe, A.
Rehm, D.
Durham, S.
ALLERGY, 2011, 66 : 301 - 301
[7] Efficacy of SQ-standardised grass allergy immunotherapy tablet treatment on basophil activation test in subjects with grass pollen induced rhinoconjuctivitis
Serra, P.
Di Martino, M.
Muggianu, E.
Corrias, C.
Manconi, P.
Milani, M.
ALLERGY, 2010, 65 : 268 - 268
[8] Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Durham, Stephen R.
Emminger, Waltraud
Kapp, Alexander
Colombo, Giselda
de Monchy, Jan G. R.
Rak, Sabina
Scadding, Glenis K.
Andersen, Jens S.
Riis, Bente
Dahl, Ronald
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (01) : 131 - 138
[9] Quality of life during routine treatment with the SQ-standardised grass allergy immunotherapy tablet
Horn, A.
Zeuner, H.
Wolf, H.
Schnitker, J.
Wuestenberg, E.
ALLERGY, 2010, 65 : 579 - 580
[10] Treatment satisfaction during routine treatment with the SQ-standardised grass allergy immunotherapy tablet
Liefold, N.
Wuestenberg, E.
Schnitker, J.
Wolf, H.
ALLERGY, 2010, 65 : 569 - 569

← 1 2 3 4 5 →